Primary |
Abdominal Pain Upper |
100.0% |
|
Overdose |
50.0% |
Pancreatitis |
50.0% |
|
Secondary |
Migraine |
19.4% |
Osteoarthritis |
19.4% |
Asthma |
12.9% |
Ill-defined Disorder |
8.6% |
Drug Use For Unknown Indication |
7.9% |
Hypothyroidism |
7.2% |
Deep Vein Thrombosis |
6.5% |
Epilepsy |
5.8% |
Nasopharyngitis |
5.0% |
Pain |
2.2% |
Product Used For Unknown Indication |
2.2% |
Bronchopneumonia |
1.4% |
Tonsillitis |
1.4% |
|
Dyspnoea |
47.1% |
Emergency Care Examination Abnormal |
5.9% |
Inappropriate Schedule Of Drug Administration |
5.9% |
Intentional Overdose |
5.9% |
Pancreatitis Acute |
5.9% |
Respiratory Rate Decreased |
5.9% |
Small Intestinal Perforation |
5.9% |
Stevens-johnson Syndrome |
5.9% |
Therapy Non-responder |
5.9% |
Toxic Epidermal Necrolysis |
5.9% |
|
Concomitant |
Lung Adenocarcinoma |
15.9% |
Product Used For Unknown Indication |
11.9% |
Depression |
10.1% |
General Anaesthesia |
7.9% |
Multiple Myeloma |
7.9% |
Lung Squamous Cell Carcinoma Stage Unspecified |
5.3% |
Osteoporosis |
5.3% |
Induction Of Anaesthesia |
4.4% |
Pancreatic Carcinoma Metastatic |
3.5% |
Prophylaxis Of Nausea And Vomiting |
3.5% |
Maintenance Of Anaesthesia |
3.1% |
Neuralgia |
3.1% |
Parkinson's Disease |
3.1% |
Non-small Cell Lung Cancer |
2.6% |
Hypertension |
2.2% |
Lower Respiratory Tract Infection |
2.2% |
Musculoskeletal Pain |
2.2% |
Non-small Cell Lung Cancer Metastatic |
2.2% |
Adenosquamous Cell Lung Cancer |
1.8% |
Cardiac Failure |
1.8% |
|
Rash |
11.0% |
Vomiting |
8.2% |
Gastrointestinal Haemorrhage |
6.8% |
Pneumothorax |
6.8% |
Respiratory Failure |
6.8% |
Oedema Peripheral |
5.5% |
Pneumonia |
5.5% |
Rhabdomyolysis |
5.5% |
White Blood Cell Count Increased |
5.5% |
Drug Exposure During Pregnancy |
4.1% |
International Normalised Ratio Increased |
4.1% |
Renal Failure Acute |
4.1% |
Skin Ulcer |
4.1% |
Sputum Culture Positive |
4.1% |
Toxic Epidermal Necrolysis |
4.1% |
Agranulocytosis |
2.7% |
Duodenal Ulcer Perforation |
2.7% |
Dyspnoea |
2.7% |
Erectile Dysfunction |
2.7% |
Haematemesis |
2.7% |
|